487 related articles for article (PubMed ID: 11527248)
1. Cromolyn sodium suppresses eosinophilic inflammation in patients with aspirin-intolerant asthma.
Amayasu H; Nakabayashi M; Akahori K; Ishizaki Y; Shoji T; Nakagawa H; Hasegawa H; Yoshida S
Ann Allergy Asthma Immunol; 2001 Aug; 87(2):146-50. PubMed ID: 11527248
[TBL] [Abstract][Full Text] [Related]
2. Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma.
Amayasu H; Yoshida S; Ebana S; Yamamoto Y; Nishikawa T; Shoji T; Nakagawa H; Hasegawa H; Nakabayashi M; Ishizaki Y
Ann Allergy Asthma Immunol; 2000 Jun; 84(6):594-8. PubMed ID: 10875487
[TBL] [Abstract][Full Text] [Related]
3. Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma.
Yoshida S; Amayasu H; Sakamoto H; Onuma K; Shoji T; Nakagawa H; Tajima T
Ann Allergy Asthma Immunol; 1998 Feb; 80(2):171-6. PubMed ID: 9494450
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effect of roxithromycin in patients with aspirin-intolerant asthma.
Shoji T; Yoshida S; Sakamoto H; Hasegawa H; Nakagawa H; Amayasu H
Clin Exp Allergy; 1999 Jul; 29(7):950-6. PubMed ID: 10383596
[TBL] [Abstract][Full Text] [Related]
5. Bronchial hyperresponsiveness, hypersensitivity to analgesics and urinary leukotriene E4 excretion in patients with aspirin-intolerant asthma.
Yoshida S; Nakagawa H; Yamawaki Y; Sakamoto H; Akahori K; Nakabayashi M; Sakamoto M; Hasegawa H; Shoji T; Tajimab T; Amayasu H
Int Arch Allergy Immunol; 1998 Oct; 117(2):146-51. PubMed ID: 9784659
[TBL] [Abstract][Full Text] [Related]
6. Relationship between induced sputum cell counts and fluid-phase eosinophil cationic protein and clinical or physiologic profiles in mild asthma.
Gutiérrez V; Prieto L; Torres V; Trenor R; Pérez C; Bertó JM; Marín J
Ann Allergy Asthma Immunol; 1999 Jun; 82(6):559-65. PubMed ID: 10400484
[TBL] [Abstract][Full Text] [Related]
7. [Sensitivity of sputum eosinophil cationic protein level for monitoring asthmatic patients with normal peak expiratory flow].
Nakazawa T; Kagami M; Matumura R; Kawashima T; Matuzuwa Y; Takada M
Arerugi; 1999 Oct; 48(10):1153-60. PubMed ID: 10554401
[TBL] [Abstract][Full Text] [Related]
8. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients.
Obase Y; Shimoda T; Tomari SY; Mitsuta K; Kawano T; Matsuse H; Kohno S
Chest; 2002 Jan; 121(1):143-50. PubMed ID: 11796443
[TBL] [Abstract][Full Text] [Related]
9. Correlation between airway hyperresponsiveness and airway inflammation in a young adult population: eosinophil, ECP, and cytokine levels in induced sputum.
Obase Y; Shimoda T; Mitsuta K; Matsuo N; Matsuse H; Kohno S
Ann Allergy Asthma Immunol; 2001 Mar; 86(3):304-10. PubMed ID: 11289329
[TBL] [Abstract][Full Text] [Related]
10. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal.
Lönnkvist K; Hellman C; Lundahl J; Halldén G; Hedlin G
J Allergy Clin Immunol; 2001 May; 107(5):812-7. PubMed ID: 11344347
[TBL] [Abstract][Full Text] [Related]
11. Effect of pranlukast on bronchial inflammation in patients with asthma.
Yoshida S; Ishizaki Y; Shoji T; Onuma K; Nakagawa H; Nakabayashi M; Akahori K; Hasegawa H; Amayasu H
Clin Exp Allergy; 2000 Jul; 30(7):1008-14. PubMed ID: 10848924
[TBL] [Abstract][Full Text] [Related]
12. [The effect of salmeterol on the number of hypodense eosinophils, eosinophilic cationic protein levels ECP in serum, bronchial hyperresponsiveness and lung function test in patients with bronchial asthma].
Chazan R; Grubek-Jaworska H; Hermanowicz-Salomon J; Droszcz W
Pol Merkur Lekarski; 1997 Oct; 3(16):180-2. PubMed ID: 9461726
[TBL] [Abstract][Full Text] [Related]
13. A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5'-monophosphate in asthmatic patients.
Taylor DA; Jensen MW; Kanabar V; Engelstätter R; Steinijans VW; Barnes PJ; O'Connor BJ
Am J Respir Crit Care Med; 1999 Jul; 160(1):237-43. PubMed ID: 10390406
[TBL] [Abstract][Full Text] [Related]
14. Sputum eosinophil counts and eosinophil cationic protein levels in cough-variant asthma and in classic asthma, and their relationships to airway hypersensitivity or maximal airway response to methacholine.
Yoo Y; Koh YY; Kang H; Yu J; Nah KM; Kim CK
Allergy; 2004 Oct; 59(10):1055-62. PubMed ID: 15355463
[TBL] [Abstract][Full Text] [Related]
15. Salmeterol decreases eosinophilic cationic protein and rescue medication in patients inhaling beclomethasone dipropionate: preliminary study in mild and moderate asthma in Trinidad, West Indies.
Pinto Pereira LM; Clement Y; Rouse J; Matthew J; Asgarali Z; Ramoutar D; Teelucksingh S
Int J Clin Pharmacol Res; 2003; 23(2-3):69-74. PubMed ID: 15025036
[TBL] [Abstract][Full Text] [Related]
16. [Sodium cromoglycate nebulized solution has an acute bronchodilative effect in patients with aspirin-intolerant asthma (AIA)].
Imokawa S; Sato A; Taniguchi M; Toyoshima M; Nakazawa K; Hayakawa H; Chida K
Arerugi; 1992 Oct; 41(10):1515-20. PubMed ID: 1482300
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of leukotriene receptor antagonist in bronchial hyperresponsiveness and hypersensitivity to analgesic in aspirin-intolerant asthma.
Yoshida S; Sakamoto H; Ishizaki Y; Onuma K; Shoji T; Nakagawa H; Hasegawa H; Nakabayashi M; Amayasu H
Clin Exp Allergy; 2000 Jan; 30(1):64-70. PubMed ID: 10606932
[TBL] [Abstract][Full Text] [Related]
18. Induced sputum to assess airway inflammation: a study of reproducibility.
Spanevello A; Migliori GB; Sharara A; Ballardini L; Bridge P; Pisati P; Neri M; Ind PW
Clin Exp Allergy; 1997 Oct; 27(10):1138-44. PubMed ID: 9383253
[TBL] [Abstract][Full Text] [Related]
19. Safety and application of induced sputum analysis in childhood asthma.
Covar RA; Spahn JD; Martin RJ; Silkoff PE; Sundstrom DA; Murphy J; Szefler SJ
J Allergy Clin Immunol; 2004 Sep; 114(3):575-82. PubMed ID: 15356559
[TBL] [Abstract][Full Text] [Related]
20. [The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation].
Ohbayashi H
Arerugi; 2005 Jan; 54(1):24-35. PubMed ID: 15841673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
